Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $5.9 million.
- Zhengye Biotechnology Holding's Accounts Payables changed N/A to $5.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.9 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is 746.18% down from last year.
- According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Accounts Payables is $5.9 million.
- In the past 5 years, Zhengye Biotechnology Holding's Accounts Payables registered a high of $6.3 million during Q4 2023, and its lowest value of $5.9 million during Q2 2025.
- Moreover, its 3-year median value for Accounts Payables was $6.0 million (2024), whereas its average is $6.1 million.
- The largest annual percentage gain for Zhengye Biotechnology Holding's Accounts Payables in the last 5 years was 568.88% (2024), contrasted with its biggest fall of 568.88% (2024).
- Zhengye Biotechnology Holding's Accounts Payables (Quarter) stood at $6.3 million in 2023, then fell by 5.69% to $6.0 million in 2024, then dropped by 1.06% to $5.9 million in 2025.
- Its Accounts Payables was $5.9 million in Q2 2025, compared to $6.0 million in Q4 2024 and $6.3 million in Q4 2023.